ITUS Corp Share Price OTC Bulletin Board
Stocks
ITUS
US45069V1044
Biotechnology & Medical Research
|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| Market Cap | 10Cr 9.38Cr 8.75Cr 7.95Cr 15Cr 1.02TCr 15Cr 105.17Cr 41Cr 516.5Cr 39Cr 39Cr 1.66TCr | P/E 2026 * |
-9.74x | P/E 2027 * | -9.01x |
|---|---|---|---|---|---|
| Enterprise Value | 10Cr 9.38Cr 8.75Cr 7.95Cr 15Cr 1.02TCr 15Cr 105.17Cr 41Cr 516.5Cr 39Cr 39Cr 1.66TCr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
94.38% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ITUS Corp
| Manager | Title | Age | Since |
|---|---|---|---|
Amit D. Kumar
CEO | Chief Executive Officer | 62 | 07/07/2017 |
Michael Catelani
DFI | Director of Finance/CFO | 60 | 01/11/2016 |
Pamela Garzone
PRN | Corporate Officer/Principal | 72 | 07/09/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Amit D. Kumar
CHM | Chairman | 62 | 01/08/2016 |
Lewis Titterton
CHM | Chairman | 82 | 01/07/1999 |
Arnold Baskies
BRD | Director/Board Member | 77 | 01/09/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.16% | +4.16% | +49.37% | +94.17% | 7.47TCr | |
| +0.46% | -0.97% | +23.51% | +79.57% | 5.88TCr | |
| +0.17% | +0.35% | +6.85% | +34.55% | 4.84TCr | |
| -0.26% | -2.44% | +330.00% | +686.22% | 4.28TCr | |
| -0.44% | -3.84% | +28.71% | +29.57% | 4.28TCr | |
| +0.29% | -0.40% | +6.69% | +110.93% | 4.12TCr | |
| -0.11% | +1.96% | +9.19% | +52.66% | 3.11TCr | |
| -2.07% | +1.16% | +35.00% | +26.28% | 3.03TCr | |
| +0.46% | -1.94% | -9.12% | -11.82% | 2.4TCr | |
| Average | +0.24% | -0.25% | +53.36% | +122.46% | 4.38TCr | |
| Weighted average by Cap. | +0.63% | -0.54% | +56.23% | +128.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.04Cr -93.31L -87.06L -79.08L -1.49Cr -101.03Cr -1.5Cr -10Cr -4.09Cr -51Cr -3.92Cr -3.84Cr -165.17Cr | -1.23Cr -1.1Cr -1.02Cr -93.02L -1.75Cr -118.84Cr -1.76Cr -12Cr -4.81Cr -60Cr -4.61Cr -4.51Cr -194.29Cr |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ANIX Stock
- ITUS Stock
Select your edition
All financial news and data tailored to specific country editions
